financetom
Business
financetom
/
Business
/
Hormel Foods Fiscal Q4 Adjusted Earnings Flat, Revenue Declines; Fiscal 2025 Guidance Set; Shares Decline Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hormel Foods Fiscal Q4 Adjusted Earnings Flat, Revenue Declines; Fiscal 2025 Guidance Set; Shares Decline Pre-Bell
Dec 4, 2024 3:50 AM

06:32 AM EST, 12/04/2024 (MT Newswires) -- Hormel Foods ( HRL ) reported fiscal Q4 adjusted earnings Wednesday of $0.42 per diluted share, the same as a year earlier.

Analysts polled by FactSet expected $0.42.

Net sales for the fiscal quarter ended Oct. 27 was $3.14 billion, down from $3.20 billion a year earlier.

Analysts surveyed by FactSet expected $3.14 billion.

The meat producer said it expects fiscal 2025 adjusted diluted EPS of $1.58 to $1.72 on net sales of $11.9 billion to $12.2 billion. Analysts polled by FactSet expect adjusted EPS of $1.68 on sales of $12.18 billion.

Shares of the company were down almost 3% in recent Wednesday premarket trading.

Price: 30.68, Change: -1.14, Percent Change: -3.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FAA issues ground stop at Hartsfield-Jackson Atlanta International airport due to gas smell
US FAA issues ground stop at Hartsfield-Jackson Atlanta International airport due to gas smell
Oct 10, 2025
WASHINGTON, Oct 10 (Reuters) - A ground stop has been issued for Hartsfield-Jackson Atlanta International airport due to a strong gas smell, the U.S. Federal Aviation Administration said on Friday. The airport is a major hub for Delta Air Lines ( DAL ). ...
Bicara Therapeutics Insider Sold Shares Worth $405,900, According to a Recent SEC Filing
Bicara Therapeutics Insider Sold Shares Worth $405,900, According to a Recent SEC Filing
Oct 10, 2025
05:26 PM EDT, 10/10/2025 (MT Newswires) -- David Raben, Chief Medical Officer, on October 09, 2025, sold 22,000 shares in Bicara Therapeutics ( BCAX ) for $405,900. Following the Form 4 filing with the SEC, Raben has control over a total of 35,497 common shares of the company, with 35,497 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203467925000003/xslF345X05/wk-form4_1760131397.xml ...
Central Bancompany files for US IPO
Central Bancompany files for US IPO
Oct 10, 2025
(Reuters) -Bank holding firm Central Bancompany ( CBCY ) on Friday filed for an initial public offering in the United States. U.S. IPO momentum has strengthened in recent months as investors return to riskier assets following a lull tied to trade tension-related market volatility. Central Bancompany ( CBCY ) will list on the Nasdaq under the ticker symbol CBC. Morgan...
Satellogic Insider Sold Shares Worth $1,641,615, According to a Recent SEC Filing
Satellogic Insider Sold Shares Worth $1,641,615, According to a Recent SEC Filing
Oct 10, 2025
05:23 PM EDT, 10/10/2025 (MT Newswires) -- Emiliano Kargieman, 10% Owner, Director, Chief Executive Officer, on October 08, 2025, sold 402,303 shares in Satellogic ( SATL ) for $1,641,615. Following the Form 4 filing with the SEC, Kargieman has control over a total of 1,617,643 Class A common shares of the company, with 1,617,643 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1874315/000189758025000023/xslF345X05/wk-form4_1760131099.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved